Business Wire

VISIT-HARDANGERFJORD

21.6.2024 13:11:35 CEST | Business Wire | Press release

Share
Norwegian Natural Wonder Trolltunga Shines as an International Wedding Hotspot

Trolltunga, Norway's most spectacular rock formation, has become a dream wedding destination. This year, a record number of couples exchanged vows on the longest day of the year, with ceremonies lasting until midnight on the Instagram hotspot.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240621968668/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

"We came across a post on social media, and it feels surreal to finally be standing here on Trolltunga. We have been looking forward to this for a long time. It is incredible", explains Daniele Arcuri & Lavinia Paretti. (Photo: Business Wire)

For the first time, wedding ceremonies on Trolltunga lasted until midnight to accommodate a record number of couples. Conducting the ceremonies on the longest day of the year – the day with the most daylight – provided a unique and unforgettable wedding backdrop.

"We wanted to do something special for our wedding, and now we are standing in the most beautiful nature we have ever seen. We are almost speechless. This was a truly fantastic experience", says Daniele Arcuri & Lavinia Paretti from Italy.

An International Dream

Mayor Roald Aga Haug married twenty couples from 11 countries, including Norway, Scotland, Germany, Romania, Italy, Poland, Costa Rica, Latvia, Lithuania, Sweden, and Denmark. Multiple couples describe it as a "dream to be married in the Norwegian nature" and feel "blessed to be allowed to do this."

"We loved it. This was exactly what we wanted and came to Norway & Trolltunga for", says Federica Migliori and Luka Landucci, who also travelled from Italy.

A Growing Trend in Fairytale Landscape

Interest in nature weddings in Norway has increased significantly in recent years. When the possibility was first introduced, three couples got married on Trolltunga. The number has now grown to 20 couples for several reasons. Record-high temperatures in Europe have sparked massive interest in the Norwegian fjords. Never before have there been so many tourists in the Hardangerfjord region – just outside Bergen.

The wedding day started with a 10-kilometer hike to Trolltunga. Equipment and wedding dresses were transported by helicopter, and several tents were set up for the couples to change before the ceremonies. Local musicians played captivating music to set the right mood during the ceremonies.

A Revitalized Region

Although weddings do not generate significant income, the increased interest in vacationing in Norway and Hardanger has led to million-dollar regional investments. The area is now flourishing with new activities and attractions every year. Hardanger, including Trolltunga, has become one of the most popular destinations in Norway.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240621968668/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release

Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar

ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release

First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno

BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release

Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures

IHS Towers Publishes 2025 Sustainability Report26.5.2026 12:34:00 CEST | Press release

IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi

Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 12:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye